Severe immune-mediated thrombocytopenia after intravitreal bevacizumab injection
Conclusion:
The case presented shows apparent severe immune-mediated thrombocytopenia after intravitreal bevacizumab administration.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research
More News: Avastin | Bone Marrow Aspiration and Biopsy | Opthalmology | Papanicolaou (Pap) Smear | Rituxan | Study | Thrombocytopenia | Vitamin A